MUC16: molecular analysis and its functional implications in benign and malignant conditions-Reference-Cited by-同舟云学术

MUC16: molecular analysis and its functional implications in benign and malignant conditions

Published:2014-07-02 Issue:10 Volume:28 Page:4183-4199
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Haridas Dhanya¹,Ponnusamy Moorthy P.¹,Chugh Seema¹,Lakshmanan Imayavaramban¹,Seshacharyulu Parthasarathy¹,Batra Surinder K.¹²³

Affiliation:

1. Department of Biochemistry and Molecular BiologyUniversity of Nebraska Medical CenterOmahaNebraskaUSA

2. Fred and Pamela Buffett Cancer CenterEppley Institute for Research in Cancer and Allied DiseasesUniversity of Nebraska Medical CenterOmahaNebraskaUSA

3. Department of Pathology and MicrobiologyUniversity of Nebraska Medical CenterOmahaNebraskaUSA

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.14-257352

Reference138 articles.

1. Mucin-based Targeted Pancreatic Cancer Therapy

2. Current status of mucins in the diagnosis and therapy of cancer

3. Structural organization and classification of the human mucin genes

4. Mucins and mucin binding proteins in colorectal cancer

5. Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycomics of cervicovaginal fluid from women at risk of preterm birth reveals immuno-regulatory epitopes that are hallmarks of cancer and viral glycosylation;Scientific Reports;2024-09-06

2. PD-1-CD28-enhanced receptor and CD19 CAR-modified tumor-infiltrating T lymphocytes produce potential anti-tumor ability in solid tumors;Biomedicine & Pharmacotherapy;2024-06

3. MUC16: clinical targets with great potential;Clinical and Experimental Medicine;2024-05-17

4. Structural basis for antibody recognition of the proximal MUC16 ectodomain;Journal of Ovarian Research;2024-02-19

5. In silico Screening and Validation of Achyranthes aspera as a Potential Inhibitor of BRAF and NRAS in Controlling Thyroid Cancer;Anti-Cancer Agents in Medicinal Chemistry;2023-11